Cancer trial challenges high steroid use before chemo
NCT ID NCT02776436
Summary
This study tested whether it is safe to lower the high dose of the steroid dexamethasone given to patients before docetaxel chemotherapy. It involved 46 people with breast or prostate cancer. The goal was to find the lowest effective steroid dose to prevent allergic and swelling reactions, while reducing steroid side effects like blood sugar problems and mood changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Haga hospital
The Hague, Netherlands
-
Leiden university medical center
Leiden, Netherlands
-
Reinier de Graaf hospital
Delft, Netherlands
Conditions
Explore the condition pages connected to this study.